The Washington State Liquor and Cannabis Board (WSLCB) is the primary adult use cannabis regulatory authority in the State of Washington. The executive agency, which also regulates alcohol, tobacco, and vapor products in Washington state, is overseen by a three member board appointed by the Governor to six-year terms. The Board holds regular public meetings and work sessions with stakeholders, makes policy and budget decisions, and adjudicates contested license applications and enforcement actions on licensees. Board members are also responsible for hiring the agency's Director, who manages day-to-day operations.
Washington State Liquor and Cannabis Board
(WSLCB)
Public
Observations
The Week Ahead
(September 27, 2021)
WSLCB staff would attempt to clarify their intent to reform cannabis law in Washington state, while CANNRA leaders educated public health and prevention practitioners on similar subjects.
WA SECTF - Public Meeting
(September 14, 2021) - Legislative Proposals - Licensing
Three recommendations for the 2022 legislative session were put forward by the licensing work group and adopted by the task force following discussion and amendment.
WSLCB - Board Meeting
(October 31, 2018) - HB 2334 Implementation - CR-103
Board members adopted rules on importation of CBD products for use as additives - but would soon have to approve an interim policy creating an exemption from traceability requirements.
The Week Ahead
(September 20, 2021)
The social equity licensing work group would learn about “Social Consumption Lounges” and the Cannabis Alliance planned to host state officials to discuss crucial contemporary topics.
WSLCB - Board Meeting
(September 15, 2021) - Summary
The board began rescinding unnecessary interim policies, heard rulemaking updates, and a licensee called for more time to transition from seed-to-sale traceability to weekly reporting.
WA Commission for Measurement of Tax Preferences - Public Meeting
(September 9, 2021) - Medical Cannabis
A single patient offered testimony recommending sales tax breaks be reserved for registered patient purchases of DOH compliant products to incentivize “medical grade” production.
WSLCB - Board Meeting
(October 3, 2018) - HB 2334 Implementation - Public Hearing
A public hearing on the implementation of imported CBD rules drew suggested revisions on cannabis product testing standards from the public and a WSDA pesticide official.
The Week Ahead
(September 13, 2021)
The social equity task force was scheduled to review significant legislative proposals developed by work group members, and WSDA opened its pesticide penalty regime for revision.
WSLCB - Executive Management Team
(September 8, 2021) - Agency Request Legislation
The board heard about two agency request bills: a joint venture with WSDA to regulate testing lab standards and one “to allow for synthetic, but to prohibit artificial” cannabinoids in products.
WSLCB - Webinar - CCRS
(September 8, 2021) - Summary
Staff provided more specifics on processes and standards for compliance reporting under the Cannabis Central Reporting System (CCRS) and responded to 50 pre-submitted questions.